Klinik für Dermatologie, Venerologie und Allergologie

Autoimmunerkrankungen

T regulatory cells in bullous autoimmune dermatoses

Ansprechpartner:
Frau Susok, Assistenzärztin
Telefon:
0234 / 509-3431

 


T regulatory cells in leucocytoclastic vasculitis

Ansprechpartner:
Frau Susok, Assistenzärztin
Telefon:
0234 / 509-3431

 


A multi-center, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and tolerability of KRP203 in patients with active subacute cutaneous lupus erythematodes

Ansprechpartner:
Frau Allrich, Study Nurse
Telefon:
0234 / 509-3415

 


Prospective, randomized, placebo-controlled, double-blind, multicenter, parallel group study to assess the efficacy, safety and tolerability of macitentan in patients with ischemic digital ulcers associated with systemic sclerosis

Ansprechpartner:
Frau Susok, Assistenzärztin
Telefon:
0234 / 509-3431

 


A phase II/III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of tocilizumab versus placebo in patients with systemic sclerosis

Ansprechpartner:
Frau Allrich, Study Nurse
Telefon:
0234 / 509-3415

 


IA-Pem-Studie – Immunadsorption bei Pemphigus vulgaris



Ansprechpartner:
Fr. Allrich, Study Nurse
Telefon:
0234/509-3415